Junfeng Liu
Impact in
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Lung Cancer Diagnosis and Treatment 6
- Lung Cancer Treatments and Mutations 6
- Pulmonary Hypertension Research and Treatments 4
-
- RNA modifications and cancer 5
- Co-authors
- Chun Chen (4 shared papers)Dongsheng Yue (3 shared papers)Yi Shen (3 shared papers)Heng Zhao (3 shared papers)Weimin Mao (3 shared papers)Haitao Ma (2 shared papers)Qun Wang (2 shared papers)Xiaofei Li (3 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)Medicine (2 papers)Diseases of the Esophagus (1 paper)BMJ Open (1 paper)Journal of Gastroenterology and Hepatology (1 paper)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Junfeng Liu
43 papers receiving 759 citations
Peers
Comparison fields: 5 of 86
- Pulmonary and Respiratory Medicine 312
- Cancer Research 147
- Oncology 153
- Immunology 58
- Surgery 110
Countries citing papers authored by Junfeng Liu
This map shows the geographic impact of Junfeng Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junfeng Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junfeng Liu more than expected).
Fields of papers citing papers by Junfeng Liu
This network shows the impact of papers produced by Junfeng Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junfeng Liu. The network helps show where Junfeng Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Junfeng Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 183 | |
| 2 | 2010 | 61 | |
| 3 | 2015 | 55 | |
| 4 | 2019 | 50 | |
| 5 | 2016 | 47 | |
| 6 | 2022 | 43 | |
| 7 | 2023 | 35 | |
| 8 | 2022 | 31 | |
| 9 | 2006 | 27 | |
| 10 | 2022 | 26 | |
| 11 | 2015 | 25 | |
| 12 | 2016 | 18 | |
| 13 | 2013 | 13 | |
| 14 | 2011 | 13 | |
| 15 | 2015 | 13 | |
| 16 | 2015 | 13 | |
| 17 | 2020 | 11 | |
| 18 | 2020 | 10 | |
| 19 | 2013 | 10 | |
| 20 | 2020 | 9 |
About Junfeng Liu
Junfeng Liu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research, Oncology and Surgery, having authored 47 papers that have together received 769 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (6 papers), Lung Cancer Treatments and Mutations (6 papers), MicroRNA in disease regulation (5 papers), RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (4 papers), Pulmonary Hypertension Research and Treatments (4 papers), Peptidase Inhibition and Analysis (3 papers) and Lung Cancer Research Studies (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (312 citations), Cancer Research (147 citations), Oncology (153 citations), Immunology (58 citations) and Surgery (110 citations). Junfeng Liu has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Chun Chen, Dongsheng Yue, Yi Shen, Heng Zhao, Weimin Mao, Haitao Ma, Qun Wang, Xiaofei Li, Shidong Xu and Yongyu Liu. Their work appears in journals such as Journal of Clinical Oncology, Medicine, Diseases of the Esophagus, BMJ Open and Journal of Gastroenterology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.